Bodal Chemicals: Minutes of the 39th AGM held on 26th September 2025
Bodal Chemicals held its 39th AGM on September 26, 2025, approving financial results, reappointing directors, and ratifying auditor remuneration. Key resolutions were passed with requisite majority.
The passing of resolutions regarding key appointments and financial matters has a moderate impact on the company's governance and operational continuity. The re-appointment of directors and auditors ensures stability, while the approval of financial statements reflects the company's performance.
The announcement primarily focuses on the successful completion of the AGM and the passing of key resolutions, including the adoption of financial statements and the re-appointment of key personnel. The chairman's speech highlights positive developments and future strategies.
* The 39th Annual General Meeting (AGM) of Bodal Chemicals Limited was held on Friday, 26th September 2025, via video conferencing and concluded at 12:22 P.M. * Shri Suresh J. Patel, Chairman & Managing Director, welcomed the members and directors, highlighting FY25 achievements amidst global challenges. * Key points from the Chairman's speech: * The company showed resilience amidst volatility, inflationary headwinds, and shifting trade dynamics. * The Dye Intermediates division delivered strong volume growth. * The Dyestuffs division grew across India and Southeast Asia. * The Chlor-Alkali business registered promising growth. * Export volumes experienced a healthy increase. * Operations were reinitiated through the domestic trading arm, BCTPL. * A new greenfield manufacturing facility at Saykha, Gujarat, was commissioned, enabling entry into the benzene derivatives segment. * Resolutions passed during the AGM include: * Adoption of audited standalone and consolidated financial statements for the year ended 31st March 2025. * Re-appointment of Mr. Rajarshi Ghosh as Director-HSE. * Approval for the appointment of M/s. B N P S and Associates LLP as Statutory Auditor. * Ratification of the remuneration of Cost Auditors for the financial year 2025-26 at ₹1,65,000 plus GST. * Appointment of M/s Shah & Shah Associates as Secretarial Auditor from FY2025-26 to FY2029-30. * Re-appointment of Mr. Mayank K. Mehta as an Independent Director for a second term of five years, commencing from 8th February 2026 up to 8th February 2031. * Re-appointment of Mr. Suresh J. Patel as Chairman and Managing Director for three years, effective 13th May 2026, with a basic salary of ₹9,00,000 per month and commission up to 3% of net profit. * Re-appointment of Mr. Bhavin S. Patel as Executive Director for three years, effective 13th May 2026, with a basic salary of ₹6,00,000 per month and commission up to 2% of net profit.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.